Skip to main content

Use of antipyretics for preventing febrile seizure recurrence in children: a systematic review and meta-analysis

European Journal of Pediatrics volume 180, pages 987–997 (2021)Cite this article

Abstract

The efficacy of antipyretics for preventing febrile seizure recurrence has been reported by a recent study, and the results might overturn previous evidence. We systematically reviewed the efficacy of antipyretics in the prevention of febrile seizure recurrence in children focused on the timing of its administration. We searched the Medline, Embase, and Cochrane Central Register of Controlled Trials databases for randomized and quasi-randomized trials and prospective non-randomized studies of aged up to 60 months, diagnosed with febrile seizure, who were treated with antipyretics. Data were extracted from eight studies. Only one study reported that antipyretics prevented the recurrence of febrile seizures within the same fever episode (9.1% in the acetaminophen group vs. 23.5% in the control group, p < 0.01). Four studies found no evidence for the efficacy of antipyretics in preventing febrile seizure recurrence in distant fever episodes (odds ratio, 0.92; 95% confidence interval, 0.57–1.48, for two randomized controlled studies).

Conclusion: This review provides very limited support for the use of antipyretics in preventing febrile seizure recurrence within the same fever episode and no evidence for its use in distant fever episodes. New studies are required to evaluate this topic further and determine whether the effectiveness of antipyretics is based on intervention timing.

What is Known:
• Reviews of prophylactic drug management among febrile seizure children found that antipyretics had no significant benefits.
• Recent data suggest that antipyretics are effective in preventing febrile seizures.
What is New:
• Weak evidence suggests a possible role in preventing febrile seizure recurrence within the same fever episode.
• There is clearly no role for antipyretic prophylaxis in preventing febrile seizures during distant fever episodes.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Abbreviations

RCT:

Randomized control trials

References

  1. Hauser WA (1994) The prevalence and incidence of convulsive disorders in children. Epilepsia. 35(Suppl 2):S1–S6

    Article  Google Scholar 

  2. Vestergaard M, Pedersen CB, Sidenius P, Olsen J, Christensen J (2007) The long-term risk of epilepsy after febrile seizures in susceptible subgroups. Am J Epidemiol 165:911–918. https://doi.org/10.1093/aje/kwk086

    Article  PubMed  Google Scholar 

  3. Hirabayashi Y, Okumura A, Kondo T, Magota M, Kawabe S, Kando N, Yamaguchi H, Natsume J, Negoro T, Watanabe K (2009) Efficacy of a diazepam suppository at preventing febrile seizure recurrence during a single febrile illness. Brain and Development 31:414–418. https://doi.org/10.1016/j.braindev.2008.07.010

    Article  PubMed  Google Scholar 

  4. Offringa M, Newton R (2013) Prophylactic drug management for febrile seizures in children (review). Evid Based Child Health 8:1376–1485. https://doi.org/10.1002/ebch.1921

    Article  PubMed  Google Scholar 

  5. Offringa M, Bossuyt PM, Lubsen J et al (1994) Risk factors for seizure recurrence in children with febrile seizures: a pooled analysis of individual patient data from five studies. J Pediatr 124:574–584

    CAS  Article  Google Scholar 

  6. Bertille N, Purssell E, Hjelm N, Bilenko N, Chiappini E, de Bont EGPM, Kramer MS, Lepage P, Lava SAG, Mintegi S, Sullivan JE, Walsh A, Cohen JF, Chalumeau M (2018) Symptomatic management of febrile illnesses in children: a systematic review and meta-analysis of parents’ knowledge and behaviors and their evolution over time. Front Pediatr 6:279. https://doi.org/10.3389/fped.2018.00279

    Article  PubMed  PubMed Central  Google Scholar 

  7. Pavlidou E, Tzitiridou M, Kontopoulos E, Panteliadis CP (2008) Which factors determine febrile seizure recurrence? A prospective study. Brain Dev 30:7–13. https://doi.org/10.1016/j.braindev.2007.05.001

    Article  PubMed  Google Scholar 

  8. Tosun A, Koturoglu G, Serdaroglu G, Polat M, Kurugol Z, Gokben S, Tekgul H (2010) Ratios of nine risk factors in children with recurrent febrile seizures. Pediatr Neurol 43:177–182. https://doi.org/10.1016/j.pediatrneurol.2010.05.007

    Article  PubMed  Google Scholar 

  9. Section on Clinical Pharmacology and Therapeutics; Committee on Drugs, Sullivan JE, Farrar HC (2011) Fever and antipyretic use in children. Pediatrics. 127:580–587. https://doi.org/10.1542/peds.2010-3852

    Article  Google Scholar 

  10. Davis T (2013) NICE guideline: feverish illness in children—assessment and initial management in children younger than 5 years. Arch Dis Child Educ Pract Ed 98:232–235. https://doi.org/10.1136/archdischild-2013-304792

    Article  PubMed  Google Scholar 

  11. Chiappini E, Venturini E, Remaschi G et al (2017) 2016 Update of the Italian Pediatric Society Guidelines for management of fever in children. J Pediatr 180:177–183.e1. https://doi.org/10.1016/j.jpeds.2016.09.043

    Article  PubMed  Google Scholar 

  12. Clericetti CM, Milani GP, Bianchetti MG, Simonetti GD, Fossali EF, Balestra AM, Bozzini MA, Agostoni C, Lava SAG (2019) Systematic review finds that fever phobia is a worldwide issue among caregivers and healthcare providers. Acta Paediatr 108:1393–1397. https://doi.org/10.1111/apa.14739

    Article  PubMed  Google Scholar 

  13. Natsume J, Hamano S, Iyoda K, Kanemura H, Kubota M, Mimaki M, Niijima S, Tanabe T, Yoshinaga H, Kojimahara N, Komaki H, Sugai K, Fukuda T, Maegaki Y, Sugie H (2017) New guidelines for management of febrile seizures in Japan. Brain and Development 39:2–9. https://doi.org/10.1016/j.braindev.2016.06.003

    Article  PubMed  Google Scholar 

  14. Rosman NP, Colton T, Labazzo J, Gilbert PL, Gardella NB, Kaye EM, Bennekom CV, Winter MR (1993) A controlled trial of diazepam administered during febrile illnesses to prevent recurrence of febrile seizures. N Engl J Med 329:79–84. https://doi.org/10.1056/nejm199307083290202

    CAS  Article  PubMed  Google Scholar 

  15. Graves RC, Oehler K, Tingle LE (2012) Febrile seizures: risks, evaluation, and prognosis. Am Fam Physician 85:149–153

    PubMed  Google Scholar 

  16. Daneman D, McArthur JE (1978) The initial management of simple febrile seizures. N Z Med J 87:427–428

    CAS  PubMed  Google Scholar 

  17. Offringa M, Newton R, Cozijnsen MA, Nevitt SJ (2017) Prophylactic drug management for febrile seizures in children. Cochrane Database Syst Rev 2:Cd003031. https://doi.org/10.1002/14651858.CD003031.pub3

    Article  PubMed  Google Scholar 

  18. Rosenbloom E, Finkelstein Y, Adams-Webber T, Kozer E (2013) Do antipyretics prevent the recurrence of febrile seizures in children? A systematic review of randomized controlled trials and meta-analysis. Eur J Paediatr Neurol 17:585–588. https://doi.org/10.1016/j.ejpn.2013.04.008

    Article  PubMed  Google Scholar 

  19. Murata S, Okasora K, Tanabe T, Ogino M, Yamazaki S, Oba C, Syabana K, Nomura S, Shirasu A, Inoue K, Kashiwagi M, Tamai H (2018) Acetaminophen and febrile seizure recurrences during the same fever episode. Pediatrics. 142(5):e20181009. https://doi.org/10.1542/peds.2018-1009

    Article  PubMed  Google Scholar 

  20. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA (2011) The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 343:d5928. https://doi.org/10.1136/bmj.d5928

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, Jang BH, Son HJ (2013) Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol 66:408–414. https://doi.org/10.1016/j.jclinepi.2012.09.016

    Article  PubMed  Google Scholar 

  22. Strengell T, Uhari M, Tarkka R, Uusimaa J, Alen R, Lautala P, Rantala H (2009) Antipyretic agents for preventing recurrences of febrile seizures: randomized controlled trial. Arch Pediatr Adolesc Med 163:799–804. https://doi.org/10.1001/archpediatrics.2009.137

    Article  PubMed  Google Scholar 

  23. Uhari M, Rantala H, Vainionpaa L, Kurttila R (1995) Effect of acetaminophen and of low intermittent doses of diazepam on prevention of recurrences of febrile seizures. J Pediatr 126:991–995

    CAS  Article  Google Scholar 

  24. Van Esch A, Steyerberg EW, Moll HA, Offringa M, Hoes AW, Habbema JDF, Derksen-Lubsen G (2000) A study of the efficacy of antipyretic drugs in the prevention of febrile seizure recurrence. Ambulatory Child Health 6:19–26

    Article  Google Scholar 

  25. van Stuijvenberg M, Derksen-Lubsen G, Steyerberg EW, Habbema JD, Moll HA (1998) Randomized, controlled trial of ibuprofen syrup administered during febrile illnesses to prevent febrile seizure recurrences. Pediatrics. 102:E51

    Article  Google Scholar 

  26. Razieh F, Karbasi A, Sedighah (2010) Recurrence of febrile seizures in yazd shahid sadoughi hospital. Iran J Child Neurol 3:23–30

    Google Scholar 

  27. Van Esch A, Van Steensel-Moll HA, Steyerberg EW, Offringa M, Habbema JD, Derksen-Lubsen G (1995) Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 149:632–637

    Article  Google Scholar 

  28. Schnaiderman D, Lahat E, Sheefer T, Aladjem M (1993) Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage. Eur J Pediatr 152:747–749. https://doi.org/10.1007/BF01953992

    CAS  Article  PubMed  Google Scholar 

Download references

Funding

This study was supported by a Grant-in-Aid for the National Center for Child Health and Development. The funding was used for literature search by an information specialist, ordering of full-text papers, and English language editing.

Author information

Authors and Affiliations

  1. Center for Postgraduate Education and Training, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo, 157-8535, Japan

    Risa Hashimoto & Akira Ishiguro

  2. Department of Health Policy, National Center for Child Health and Development, Tokyo, Japan

    Risa Hashimoto, Maiko Suto, Mariko Tsuji & Kenji Takehara

  3. Medical Support Center for Japan Environment and Children’s Study, National Center for Child Health and Development, Tokyo, Japan

    Hatoko Sasaki

  4. Division of Neurology, National Center for Child Health and Development, Tokyo, Japan

    Masaya Kubota

Authors
  1. Risa Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maiko Suto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mariko Tsuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hatoko Sasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kenji Takehara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akira Ishiguro
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Masaya Kubota
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Risa Hashimoto developed the concept of the study, designed the study, selected the eligible studies, collected the data, and summarized the data, wrote the initial draft of the manuscript, and revised it. Maiko Suto designed the study, selected the eligible studies, collected the data, summarized the data, and critically reviewed and revised the manuscript. Mariko Tsuji selected the eligible studies, collected the data, summarized the data, and critically reviewed and revised the manuscript. Hatoko Sasaki checked the results of summarized data and critically reviewed and revised the manuscript. Kenji Takehara designed the study and critically reviewed and revised the manuscript. Akira Ishiguro developed the concept of the study and critically reviewed and revised the manuscript. Masaya Kubota developed the concept of the study and critically reviewed and revised the manuscript. We had complete access to the study data that support the publication. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Risa Hashimoto.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethical approval was not required for this systematic review.

Additional information

Communicated by Gregorio Paolo Milani

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 24 kb)

ESM 2

(DOCX 18 kb)

ESM 3

(DOCX 24 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Hashimoto, R., Suto, M., Tsuji, M. et al. Use of antipyretics for preventing febrile seizure recurrence in children: a systematic review and meta-analysis. Eur J Pediatr 180, 987–997 (2021). https://doi.org/10.1007/s00431-020-03845-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-020-03845-8

Keywords

  • Antipyretics
  • Antiseizure drugs
  • Febrile seizure
  • Prevention
  • Recurrence
  • Systematic review